Fig. 1 (abstract P103).
TIL Percentage Prognosticates Increased OS and RFS in Hu14.18-IL2 Treated Melanoma Patients
Fig. 1 (abstract P103). | Journal for ImmunoTherapy of Cancer
TIL Percentage Prognosticates Increased OS and RFS in Hu14.18-IL2 Treated Melanoma Patients